From Nasdaq.: 2025-04-29 16:01:00

Novo Nordisk’s stock (NYSE: NVO) increased by 3.9% on Tuesday, reaching a high of 4.5%. The rise coincided with a 0.7% increase in the S&P 500 and Nasdaq Composite. The pharma company partnered with telehealth providers to offer its drug Wegovy through their platforms, aiming to capture consumers who sought compounded versions during a U.S. shortage. This move could help Novo Nordisk compete in the GLP-1 market, despite potential trade tensions affecting margins. Investors should consider the company’s evolving strategy before deciding to invest. For more investment opportunities, check out the top 10 stocks recommended by The Motley Fool.



Read more at Nasdaq.: Why Novo Nordisk Stock Is Soaring Today